Bench International > blog new (Page 2)

“I Rest My Case!”

By DeeDee DeMan - Looking at the 2016 “report card,” on FDA approvals reinforces why we all need a knowledgeable champion like Scott Gottlieb, as FDA Commissioner. We’ve known for a few months now that 2016 was going to be a disappointing year for new drug approvals....

The Future of Drug Discovery

By Kimberly Plessala. - On the topic of artificial intelligence, I for one, tend towards the Hollywood version. Where machines eventually deciding the human race is such an imperfect system fraught with disease and intellectual thresholds that the only sensible solution is to eliminate us....

Advances in Alzheimer’s Disease

By Gail Rosenblum - Advances are being made globally in the area of Alzheimer’s disease and related dementia disorders, and Bench International has been privileged to work extensively in this field, partnering most recently with Chase Pharmaceuticals, Axovant Sciences and Bionomics Limited. Designated in 1983 by...

Another Hindrance to Gene Therapy?

By Tim Silcott - Gene Therapy has been a top topic in life science for discussion in the past few years, with many companies delving into the area. Now that the field is maturing, we are seeing some setbacks from some of the top entrants...